Procaps is a leading Latin American pharmaceutical company with a rich history of 50 years, dedicated to enhancing health and wellness across communities. Committed to quality, ethics, and sustainable results, Procaps develops, manufactures, and markets a wide range of products, including prescription medications and high-potency clinical solutions. Their portfolio features over 12 innovative pharmaceutical forms and encompasses a variety of therapeutic lines designed with scientific backing and global quality standards.

In particular, Procaps offers specialized products for diabetes management, providing comprehensive technological solutions to support daily patient care. The company operates in 11 countries throughout Latin America, with production facilities located in Colombia, Brazil, the United States, and El Salvador. They hold 45 patents and prioritize operational excellence, evidenced by 17 certifications ensuring safe and reliable processes. Procaps is not only focused on healthcare but also emphasizes corporate social responsibility, striving to transform lives through accessible health solutions.